Shyril O'Steen

Years Active: 2017-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

George S Laszlo, Johnnie J Orozco, Allie R Kehret, Margaret C Lunn-Halbert, Jenny Huo, Donald K Hamlin, D Scott Wilbur, Shannon L Dexter, Melissa L Comstock, Shyril O'Steen, Brenda M Sandmaier, Damian J Green, Roland Bruno Walter
Development of [ 211 At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies. Leukemia 36 (6) (2022)
Johnnie J Orozco, Aimee L Kenoyer, Yukang Lin, Shyril O'Steen, Rosario Guel, Margaret E Nartea, Alexandra H Hernandez, Mark D Hylarides, Darrell R Fisher, Ethan R Balkin, Donald K Hamlin, D Scott Wilbur, Kelly D Orcutt, K Dane Wittrup, Damian J Green, Ajay K Gopal, Brian G Till, Brenda M Sandmaier, Oliver W Press, John M Pagel
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA. Molecular cancer therapeutics 19 (12) (2020)
Damian J Green, Shyril O'Steen, Yukang Lin, Melissa L Comstock, Aimee L Kenoyer, Donald K Hamlin, D Scott Wilbur, Darrell R Fisher, Margaret Nartea, Mark D Hylarides, Ajay K Gopal, Theodore A Gooley, Johnnie J Orozco, Brian G Till, Kelly D Orcutt, K Dane Wittrup, Oliver W Press
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies. Blood 131 (6) (2017)

Shyril O'Steen.css-eqlu8i{font-size:small;padding-left:4px;}